Bioarray Genetics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Bioarray Genetics General Information

Description

Developer of a gene profiling platform designed to conduct predictive tests in order to transform cancer treatment decisions. The company's platform is based on a panel of genes that has minimal overlap with other commercial and research gene panels and leverages unique RNA biomarkers, phenotypic signatures, and machine learning algorithms, providing clinicians with information for the development of analytical tools, predictive tests and companion diagnostics over a patient's response to oncology drugs.

Contact Information

Formerly Known As
Bioarray Therapeutics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 400 Farmington Avenue
  • Farmington, CT 06032
  • United States
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 400 Farmington Avenue
  • Farmington, CT 06032
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioarray Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Sep-2022 Completed Out of Business
5. Later Stage VC (Series B) 25-Sep-2017 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Later Stage VC (Series A) 01-May-2015 Completed Generating Revenue
2. Seed Round 24-Mar-2014 $730K $730K Completed Startup
1. Accelerator/Incubator 01-Jan-2011 Completed Startup
To view Bioarray Genetics’s complete valuation and funding history, request access »

Bioarray Genetics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Bioarray Genetics’s complete cap table history, request access »

Bioarray Genetics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a gene profiling platform designed to conduct predictive tests in order to transform cancer treatment decis
Drug Discovery
Farmington, CT
3 As of 2022

Beverly, MA
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bioarray Genetics Competitors (37)

One of Bioarray Genetics’s 37 competitors is Genomic Expression, a Venture Capital-Backed company based in Beverly, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomic Expression Venture Capital-Backed Beverly, MA
Scipher Medicine Venture Capital-Backed Waltham, MA
Personal Genome Diagnostics Formerly VC-backed Baltimore, MD
Aitia Venture Capital-Backed Cambridge, MA
Asuragen Formerly VC-backed Austin, TX
You’re viewing 5 of 37 competitors. Get the full list »

Bioarray Genetics Patents

Bioarray Genetics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2012211964-A1 Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment Inactive 04-Feb-2011
AU-2017203060-A1 Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment Inactive 04-Feb-2011
CA-2826657-A1 Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment Inactive 04-Feb-2011
EP-2671076-A2 Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment Inactive 04-Feb-2011
EP-2671076-A4 Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment Inactive 04-Feb-2011 G16H70/60
To view Bioarray Genetics’s complete patent history, request access »

Bioarray Genetics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bioarray Genetics FAQs

  • When was Bioarray Genetics founded?

    Bioarray Genetics was founded in 2009.

  • Where is Bioarray Genetics headquartered?

    Bioarray Genetics is headquartered in Farmington, CT.

  • What is the size of Bioarray Genetics?

    Bioarray Genetics has 3 total employees.

  • What industry is Bioarray Genetics in?

    Bioarray Genetics’s primary industry is Drug Discovery.

  • Is Bioarray Genetics a private or public company?

    Bioarray Genetics is a Private company.

  • What is Bioarray Genetics’s current revenue?

    The current revenue for Bioarray Genetics is .

  • How much funding has Bioarray Genetics raised over time?

    Bioarray Genetics has raised $7.42M.

  • Who are Bioarray Genetics’s competitors?

    Genomic Expression, Scipher Medicine, Personal Genome Diagnostics, Aitia, and Asuragen are some of the 37 competitors of Bioarray Genetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process